Ilya Pharma's Unattributed Round

Ilya Pharma raised a round of funding on November 30, 2017. Investors include European Commission.

Ilya Pharma develops drug candidates for PoC in clinical phase I and II from its technology platform of lactic acid bacteria expressing different human therapeutic proteins.…

Articles about Ilya Pharma's Unattributed Round: